期刊文献+

中草药和相关保健食品引起药物性肝病的研究 被引量:25

Drug induced liver injury associated with Chinese herbal medicine and herbal related food supplements
原文传递
导出
摘要 目的分析因服用中草药或含草药成分的保健食品引起肝损害的情况。方法收集1982年至2005年诊断为"药物性肝病"患者82例。诊断根据为病史、药物史、临床表现、肝功能及其他实验室检查。最后回顾诊断,按药物性肝损伤评分进行评估。结果24年中诊断的82例"药物性肝病"患者占同期因肝功能异常住院患者的2.2%。其中男性28例,女性54例.年龄16~81岁.平均(50.1±16.9)岁。服用的与肝损伤有关药物中,减肥保健品占30.5%、皮肤科用药占12.2%、抗风湿病用药占8.5%、心血管用药占8.5%、妇科疾病用药占7.3%、肝病药占6.1%、调节血脂药占6.1%、乳房小叶增生药占3.7%、甲状腺肿块用药占3.7%、其他用药占13.4%。用药疗程6 d~6个月不等,潜伏期6 d~3个月。临床表现中.肝细胞损伤型占36.59%、胆汁淤积型占39.02%,其他为混合型,尚有10%的患者同时伴有变态反应表现。所有患者在停药后一般病情恢复较快.预后良好。结论中药和草药是引起药物性肝病的重要原因.应提高临床医师对药物引起肝损伤的认知及在治疗过程中加强监测。 Objective To investigate the drug induced liver injure(DILI) associated with Chinese herbal medicine and herbal related food supplements. Methods From 1982 to 2005, 82 consecutive patients were diagnosed as DILl based on their medication history, clinical manifestation,liver function and other laboratory tests. The final retrospection confirmatory diagnosis was made according to the interna tional scoring system for DILI. Results The 82 DILI patients(28 men, 54 females, age ranging from 16 to 81 years old) accounted for 2.2% of hospitalized patients with liver dysfunction. Among those patients with DILI, 30.5 % was caused by weight reducing drugs or food supplements, 12.2 % by drugs of dermatology, 8.5% by drugs for cardiovascular disease, 8. 5% by drugs of rheumatology, 7. 3% by drugs of gynecology, 6.1% by drugs for liver disease, 6.1% by blood-lipids modulators, 3.7% by drugs for thyroid disease, 3.7% by drugs for hyperplasia of mammary glands and 13.4% by the others. The duration of medication was from 6 days to 6 months and the incubation period was from 6 days to 3 months. DILI could be classified as acute hepatocellular injury(36. 59%), acute cholestasis(39. 02%) and mixtures (24.39 %). About 10 % patients were accompanied by allergic manifestations. All patients recovered rap idly after stopping the relevant medicine. Conclusion Chinese herbal medicine and herbal related food supplements are a common cause of DILI in China. The awareness and monitoring improving DILI during herbs treatment is a critical issue in daily practice.
出处 《中华消化杂志》 CAS CSCD 北大核心 2007年第7期435-438,共4页 Chinese Journal of Digestion
关键词 肝脏疾病 中草药 保健食品 Liver disease Drug, Chinese herbal Dietary supplements
  • 相关文献

参考文献13

  • 1Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology, 2006, 43 : 618-631.
  • 2姚光弼.重视中药和草药引起的肝损害[J].肝脏,2005,10(1):1-1. 被引量:33
  • 3Beniehou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276.
  • 4Danan G, Beniehou C. Causality assessment of adverse reactions to drugs-Ⅰ. A novel method based on the conclusions of international consensus meetings: application to -drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1330.
  • 5Maria VA, Vietotino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997, 26:664-669.
  • 6梁雁,鲁云兰,车文玺.111例药物性肝损害病例分析[J].药物不良反应杂志,2004,6(6):374-378. 被引量:16
  • 7邓培媛,傅琪.116例药源性肝损害分析[J].药物流行病学杂志,1998,7(3):142-144. 被引量:23
  • 8Farah MH, Edwards R. International monitoring of adverse health effects associated with medicines. Pharmacoepidemiol Drug Safety, 2000, 9:105-112.
  • 9Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med, 2003, 139:488-492.
  • 10Wu TN, Yang KC, Wang CM, et al. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ, 1996, 182:193-195.

二级参考文献19

  • 1许建明,胡咏梅,梅俏,徐新华,胡祥鹏,马维娟.细胞色素P4502C19基因多态性对雷贝拉唑药动学和药效学的影响[J].中华消化杂志,2004,24(10):594-597. 被引量:4
  • 2邓培媛,蔡皓东,程经华,刘顺爱,刀文彬.壮骨关节丸致肝损害30例报告[J].中国新药杂志,1996,5(3):212-214. 被引量:25
  • 3娄家驹.药源性肝病49例临床分析[J].综合临床医学,1996,12(4):197-197. 被引量:2
  • 4Arab DM, Malatjalian DA, Rittmaster RS. Sever cholestatic jaundice in uncomplicated hyperthyroddism treated with methimazole [J]. J Clin Endocrinol Metab,1995, 80(4): 1083.
  • 5Williams KV, Nayak S, Becker D, et al. Fifty years of experience with propylthiouracil associated hepatotoxicity:what have we learned? [J]. J Clin Endocrinol Metab, 1997, 82(6): 1727.
  • 6Lee WM. Drug induced hepatotoxicity [J]. N Engl J Med, 1995, 333(17): 1118.
  • 7Ernst E. Herbal medicines put into context. Their entails risks, but possibly fewer with synthetic drugs. Br Med J, 2003, 327:881-882.
  • 8Farah MH, Edwards R. International monitoring of adverse health effects associated with medicines. Pharmacoepidemiol Drug Safety, 2000, 9:105-112.
  • 9Benichou C. Criteria of drug-induced liver disorder. Report of an international consensus meeting. J Hepatol , 1990, 11: 272-276.
  • 10Danan G, Benichou C. Causality assessment of adverse reactions to drugs- I . A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol , 1993,46 : 1323-1330.

共引文献89

同被引文献242

引证文献25

二级引证文献169

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部